Top Markets
#1 Islamic Coin Islamic Coin +151.26%
#2 Akedo Akedo +76.66%
#3 Velvet Velvet +52.20%
#4 Glidr Glidr +51.75%
#5 DOVU DOVU +48.24%
#6 Black Phoenix Black Phoenix +33.87%
#7 Cross Cross +32.61%
#8 Cap Cap +20.07%
#9 DoubleZero DoubleZero +16.25%
#10 Movement Movement +9.75%
Coin of the day
Islamic Coin Islamic Coin
設定
言語
日本
通貨
USD
テーマ
BBS-Bioactive Bone Substitutes Oyj BBS-Bioactive Bone Substitutes Oyj

BBS-Bioactive Bone Substitutes Oyj

BONEH
株式のランク #39435
BBS-Bioactive Bone Substitutes Oyj operates as a Finnish biomedical technology... BBS-Bioactive Bone Substitutes Oyj operates as a Finnish biomedical technology firm, dedicated to innovating, manufacturing, and commercializing bioactive medical devices and implants for orthopedic surgical applications. The company's key offering, ARTEBONE, is an orthobiological product composed of tricalcium phosphate and a comprehensive spectrum of natural bone proteins. This solution is predominantly used for addressing bone deficiencies and aiding healing processes, especially in extremities such as the foot and ankle. BBS-Bioactive Bone Substitutes Plc commenced operations in 1991 and has its corporate headquarters situated in Oulu, Finland.
株価
$0.05828914
最終同期: 2025-03-10
時価総額
$495.40K
変化（1日）
-0.02%
変化（1年）
0.00%
国
FI
取引 BBS-Bioactive Bone Substitutes Oyj (BONEH)

カテゴリー

Healthcare
BBS-Bioactive Bone Substitutes Oyj（BONEH）のP/B比率
2026 時点のP/B比率 TTM: 0
BBS-Bioactive Bone Substitutes Oyj の最新の財務報告および株価によると、現在のP/B比率（TTM）は 0 です。2026 年末時点でのP/B比率は 0 でした。
BBS-Bioactive Bone Substitutes Oyj の P/B 比率の履歴（2026 ～ 2026）
各年末時点のP/B比率
年 P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率
企業 P/B比率 P/B比率の差 国
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 3.6048 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 5.207 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 2.0146 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 2.6697 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 4.8038 -
US